Proposed refined recommendation based on MRD at EOT and during follow-up. Assessment was conducted in patients with RUNX1-RUNX1T1⁺ AML, according to the ELN MRD Working Party,¹¹  taking into account MRD status at EOT and during follow-up. Ind, induction therapy; Cons, consolidation therapy.